HYPERTENSION IN CKD MARKET ANALYSIS

Hypertension in CKD MarketSize and Trends

The Global Hypertension in CKD Market is estimated to be valued at US$ 254.2 Mn  in 2023 and is expected to exhibit a CAGR of 10.7% during the forecast period (2023-2030).

Figure 1. Global Hypertension in CKD Market Share (%), By Drug Class 2023

Global Hypertension in CKD Market – Drivers

• Increasing collaboration for conducting research and development activities: Increasing collaboration for conducting research and development activities is expected to propel the growth of the global hypertension in CKD market over the forecast period. For instance, in March 2021, Fresenius Medical Care AG & Co. KGaA, a Germany-based global healthcare company, announced a three-way merger with InterWell Health, the leading physician organization driving innovation in the kidney care space in the U.S., and Cricket Health, a U.S. provider of value-based kidney care with a leading patient engagement and data platform, entered into a binding agreement to create an independent new company. The merger brings together Fresenius Health Partners’ expertise in kidney care value-based contracting and performance, InterWell Health’s clinical care models and strong network of 1,600 nephrologists, and Cricket Health’s tech-enabled care model that utilizes its proprietary informatics, StageSmart, and patient engagement platforms to create an innovative, stand-alone entity poised to transform kidney care.
• Increasing prevalence of chronic kidney diseases: Increasing prevalence of chronic kidney diseases is expected to increase the demand for new treatment options, thereby driving the global hypertension in CKD market growth. For instance, according to the Kidney International Supplements article ‘Epidemiology of chronic kidney disease: an update 2022 published in March 2022, Chronic kidney diseases affect around 10% of the general population worldwide, amounting to 800 Mn individuals globally. Chronic kidney disease is more prevalent in older individuals, women, racial minorities, and people experiencing diabetes mellitus and hypertension. Chronic kidney disease represents an especially large burden in low- and middle-income countries, which are least equipped to deal with its consequences. Chronic kidney disease has emerged as one of the leading causes of mortality worldwide.

Figure 2. Global Hypertension in CKD Market Share (%), By Region, 2023